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The aim of this study was to evaluate the effect of haemodialysis on lipid 
peroxidation (the level of lipid peroxidation expressed as malondialdehyde) and 
endogenous non-enzyrnic antioxidants before and after the dialysis and compared 
with control group. The sampling procedure was a purposive sampling. Twenty 
two patients with Chronic Renal Failure (CRF) disease who were haemodialysed 
at 5th AzarhospitalofGorganDialysis Center(2005). Twenty two age and sex 
matched healthy control were recruited for this study. Plasma level of 
malondialdehyde and uric acid were significantly increased and reduced in the 
postdialysis group when compared with predialysis and control group, 
respectively (p<0.001 ). The plasma level of albumin and total bilirubin were 
significantly increased in postdialysis group when compared with predialysis 
group (p<0.001). The increasing level of plasma lipid peroxidation and the 
significant difference of non-enzyrnic antioxidants in the haemodialyzed pateints 
after the process of dialysis, maybe related with the pateint uremia, the quality of 
consumed water in the dialysis procedure, dialysis membrane and the loss of 
these antioxidants through membranes and hemoconcenteration of them during 
the dialysis process and the dialysis process (may increase lipid peroxidation 
during the dialysis process). These states of affairs may play an important role 
in progress of cardiovascular abnormality in haemodialyzed pateints. Due to this 
conditions a review of haemodialysis membrane, the techniques used in the 
dialysis, the consumption of various oral antioxidant, the elimination of active 
oxygens from the dialysis surrounding are among the measures which can 
prevent sudden cardiovascular abnormality in the haemodialysis pateints and 
ultimately these important factors up- grade the pateints quality of life and 
prevent sudden silent myocardial infarction. 
Key words: 	Haemodialysis, lipid peroxidation, endogenous nonenzym1c 
antioxidants 
Department of Biochemistry and Biophysic, Faculty of Medicine, 
Golestan University of Medical Sciences, Gorgan, Iran 
681 
J. Med. Sci., 6 (4): 681-685, 2006 
INTRODUCTION 
Free radicals are highly reactive molecules generated 
by biochemical redox reactions that occur as a part of 
normal cell metabolism and in the course of free radical 
mediated diseases such as cancer, diabetes mellitus, 
cardiovascular and renal diseases (Kohen et al., 1996). 
Patients with chronic renal failure, including those 
receiving regular long-term haemodialysis have a high 
incidence of premature cardiovascular disease 
(Loughrey et al., 1994). Free radicals may cause lipid 
peroxidation (the level of lipid peroxidation expressed as 
malondialdehyde) and damage macromolcules and cellular 
structure of the organism, endothelium and erythrocytes. 
Plasma malondialdeliyde (MDA) is the breakdown 
product of the major chain reactions leading to definite 
oxidation of polyunsaturated fatty acids such as linoleic 
and linolenic acid and thus serves as a reliable marker of 
lipid peroxidation (Boaz et al., 1999; Fiorillo et al., 1998). 
Plasma 1.1DA is a predictor of cardiovascular disease in 
patients on haemodialysis, which may underscore the role 
of oxidative stress as a cardiac risk factor in these patients 
(Boaz et al., l 999b). Some studies have shown that 
haemodialysis is connected with increased free radical 
production (Bast et al., 1991 ). Cardiovascular disease is 
one of the leading cause of death in chronic renal 
failure patients on dialysis, as well as leading cause 
morbidity (Raine et al., 1992). Clinical and subclinical 
myocardial ischaemia are common among chronic 
renal failure patients, both before and during dialysis 
(Folay et al., 1995; Singh et al., 1994). The prevalence 
of ischaemic heart disease in haemodialysis patients in 
10-20 times higher than that in the general population with 
50% mortality due to Cardiovascular disease. According 
to the US Renal Data System 42% of patients undergoing 
haemodialysis have had a myocardial infarction or 
Coronary revasculariztion. In addition, the rate of survival 
after myocardial infarction 1s much lower for 
haemodialysis patients than for the general population 
(Heeschen et al., 2000). Free radicals are eliminated from 
the body by their interaction with non-enzyrnic and 
enzymic antioxidants such as uric acid, albumin, bilirubin, 
vitamins E, C, A, glutathione, glutathione peroxidase, 
superoxide dismutase and catalase. There are a few 
reports describing differences in plasma lipid peroxidation 
and non-enzyrnic antioxidants between haemodialysis 
patients and controls. Some studies show increasing, 
some others show decreasing and no any changes of 
plasma lipid peroxidation and non-enzyrnic antioxidants. 
N on-enzymic antioxidants such as uric acid, albumin and 
bilirubin are low molecular weight antioxidants which is 
important when enzymic antioxidants are in low levels. 
Because of the contradictry results in this field of study, 
the present study was designed to determine the effect of 
haemodialysis on plasma lipid peroxidation (by measuring 
the level of 1.1DA) and endogenous non-enzyrnic 
antioxidants (uric acid, albumin and total bilirubin) before 
and after the dialysis process at a Haemodialysis Center 
in Gogan City in comparison to controls. 
MATERIALS AND METHODS 
The samples were obtained in a purposive fashion, 
from 22 haemodialysis patients (mean age 43.54±9.21 
years of old) and control subjects (mean age 43.77±9.33 
years of old). The mean length of dialysis for each 
patients was 3.95±0.14 h with average 2.27±0.45 times a 
week. The patients studied had no evidence of vascular 
complications, including hypertension, coronary artery 
disease. Controls were defined as not having a major 
medical illness, no hospital admissions, no current 
medication and a subjective perception of good health as 
determined by health questionnare. None of the study 
subjects received any medical (vitamine E,C) supplement 
and non-medical antioxidants (tomato, orange, etc.). 
Patients were chosen (14 male, 8 female) from the patients 
reffered to the Department of Haemodialysis Center at the 
5th azar hospital in Gorgan City. This study was carried 
out during 2005. Blood samples were obtained after an 
overnight fast in heparinized tubes just before and after 
the process of dialysis and control group. Plasma was 
seperated soon after blood was taken. The plasma urea, 
creatinine, malondialdehyde (the level of lipid 
peroxidation expressed as malondialdehyde [1.1DA]), uric 
acid, albumin and total bilirubin were determined using 
laboratory kits and spectrophotometry techniques (model 
JENWAY 6105 UVNIS) in the laboratory of biochemistry 
(Faculty of Medicine). Plasma malondialdehyde was 
determined with Kei Satoh method (Satoh, 1978). Plasma 
urea, creatinine, uric acid, albumin and total bilirubin 
were determined using previously described methods 
(Fabiny and Erthinghausen, 1971; Henry et al., 1957; 
Doumas and Watson, 1971; Kaplan et al., 1998). Data was 
analyzed by Student's !-test, using SPSS-10 software. 
p<0.05 was considered significant. 
Malondlaldehyde measurement: To 0.5 mL plasma, 2.5 mL 
of trichloroacetic acid was added and the tube was left to 
stand for 10 min at room temperature. After centrifugation 
at 3500 RPM for 10 min, the supernatant was decanted 
and the precipitate was washed once with sulfuric acid. 
The after, 2.5 mL sulfuric acid and 3 mL thiobarbituric acid 
(TBA) in sodium sulfate were added to the precipitate and 
the coupling of lipid peroxide with TBA was carried out in 
a boiling water bath for 30 min. After cooling in cold 
water, the resulting chromogen was extracted with 4 mL of 
n-butyl alcohol by vigorous shaking. Separation of the 
organic phase was facilitated by centrifugation at 3000 
RPM for 10 min and its absorbance was determined at the 
wavelength of 530 mu. 
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Table 1: 	 The mean and standard deviation of plasma urea, creatinine, uric acid, 
albumin, total bilimbin andmalondialdehyde 
Te• Predialysis Postdialysis Control Q-value 
Urea (mg dL- 1) 123.54±8.51 55.68±7.96 26.37±4.83 <0.001 
Creatinine (mg dL-1) 15.88±3.07 1.96±0.45 1.08±0.29 <0.001 
Uric acid (mg dL- 1) 6.1±1.06 2.89±0.93 4.25±0.64 <0.001 
Albumin (g dL- 1) 3.42±0.63 3.78±0.51 3.83±0.36 <0.001 * 
Total bilimbin (mg dL- 1) 0.65±0.21 0.75±0.11 0.77±0.35 <0.001 ** 
Malondialdehyde 1.27±0.23 2.32±0.38 0.98±0.17 <0.001 
nmol mL- 1 
There was no sifgnificant differences between the postdialysis and control 
group*, There was no significant differences between the dialysis and control 
group** 
RESULTS 
As shown in Table 1 plasma level of malondialdehyde 
showed significant difference between predialysis and 
control group (p<0.001 ). It was significantly increased in 
the postdialysis group when compared with predialysis 
and control group (p<0.001, p<0.001). The plasma level of 
uric acid was significantly reduced in the postdialysis 
group when compared with predialysis and control group 
(p<0.001, p<0.001). There was also significant difference 
between control and predialysis group (p<0.001). The 
plasma level of albumin was significantly increased in 
postdialysis group when compared with predialysis group 
(p<0.001 ). It was also significant difference between 
predialysis and control group (p<0.001 ). There was no 
significant difference between the postdialysis and 
control group (p>0.05). The plasma level of total bilirubin 
was significantly increased in the postdialysis group 
when compared with the predialysis group (p<0.001 ). 
There was no significant differences between the 
(pre-, post-) dialysis and control group (p>0.05). 
DISCUSSION 
The aim of the present study was to determine the 
plasma level of malondialdehyde and endogenous non­
enzymic antioxidants in predicting the outcome of 
haemodialysis patients on regular dialysis. There are a few 
reports describing difference in plasma lipid peroxidation 
and endogenous non-enzymic antioxidants In 
haemodialyzed patients. Some of the studies showed an 
increase while some other showed a decrease or no 
significant differences. Increasing amollllt of free radicals 
probably could lead to the reduction of number of 
nephrons, golumerol filteration rate and also paranchyrnal 
lesions. The free radical also can cause the membrane lipid 
peroxidation, golumeral and renal tubules damage 
(Trachman et al., 1992). The results of this study show 
that the plasma level of malondialdehyde was significantly 
increased in postdialysis group when compared with 
predialysis and control groups. 
Canestrari et al. (1995) reported that the level of 
plasma malondialdehyde in haemodialyzed patients was 
higher than healthy controls. 
Study of Samouilidou and Grapsa (2003) on 31 
haemodialysis patients and 17 control group showed that 
plasma malondialdehyde of haemodialysis patients 
increased in the predialysis group when compared with 
postdialysis group. But the level of plasma 
malodialdehyde was higher in control groups when 
compared with postdialysis group. 
Some researchers (Ozden et al., 2002; Taylor et al., 
1992; Toborek et al., 1992; Balashova et al., 1992) 
reported that the level of plasma malondialdehyde in 
hsaemodialysis patients increased when compared with 
control groups. 
In this study we determined the level of plasma 
malodialdehyde of haemodialysis pateints before and 
after the dialysis process. Present results show a 
significant increase of plasma malondialdehyde in the 
postdialysis group when compared with the predialysis 
group. There was significant difference between the 
predialysis and postdialysis group. Present results are in 
agreement with the groups mentioned in that the 
plasma level of malondialdehyde of haemodialysis 
patients is significantly increased from that of controls 
(Loughery et al., 1994; Ozdne et al., 2002; Taylor et al., 
1992; Toborek eta/., 1992; Balashova et al., 1992). But 
the results of this study are not in agreement with the 
results of Samouilidou and Grapsa (2003) showing plasma 
of malondialdehyde of haemodialysis patients were 
significantly decreased after the dialysis process. This 
situation probably in due to direct relation between the 
blood of haemodialysis patients with dialysis instrument, 
which is an conductive factor in oxidative stress and 
subsequent increased production of free radicals in 
haemodialysis patient. The probable Oxidative destruction 
can be due to increasing production of free radicals 
(Hussain et al., 1995; Dasgupta et al., 1992). This study 
provides evidence that increased lipid peroxidation in 
haemodialysed patients is related to the dialysis process 
treatment rather than the disease itself. This situation may 
play a role in the development of atherosclerosis in 
haemodialysed groups. There are a few studies on 
changes In plasma endogenous non-enzyrnic 
antioxidants. Yihnaz et al. (2003) and Wratein et al. (2000) 
reported that plasma uric acid of haemodialysis patients 
decreased in the postdialysis group when compared with 
predialysis group. But palsma uric acid was higher in the 
predialysis group when compared with control group. 
Yilmaz et al. (2003) reported that plasma total bilirubin of 
haemodialysis patients did not show any significant 
differences in the pre- and postdialysis groups. But there 
was a meaningful increasing of plasma total bilirubin in 
the postdialysis group when compared with the 
predialysis group. 
Plasma albumin of haemodialysis patients did not 
show any significant differences in the postdialysis group 
when compared with control group. But plasma albumin 
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showed a meaningful increasing in the postdialysis and 
control groups when compared with the predialysis group 
(Yilmaz et al., 2003). 
Study ofMalliaraki et al. (2003) have shown that uric 
acid and albumin concenterations decrease and gradual 
increase during the dialysis process, respectively. In 
contrast, minor changes of total bilirubin were folllld 
during the dialysis process. Study of Gonenc et al. (2002) 
have shoV\Tll that uric acid and albumin levels increase and 
decrease during the dialysis process respectively. In 
contrast, there was not any changes of total bilirubin 
during dialysis process. The results of our study showed 
a meaningful decreasing of plasma uric acid between 
pre- and postdialysis group is thought to be related with 
the loss of antioxidant through the membranes and the 
decreased plasma uric acid maybe related to increasing of 
lipid peroxidation in haemodialyzed patients. Plasma 
albumin and total bilirubin were increased in the 
postdialysis group when compared with predialysis 
group. There were no significant differences between the 
dialysis and control group. Plasma albumin and total 
bilirubin were increased in the dialysis group probably 
due to the hemoconcenteration during the dialysis 
(Malliaraki et al., 2003). Albumin can react with most 
oxygenated species, which could lead to some oxidation­
induced changes. A study showed that the antioxidant 
effect of albumin could result from its high content in 
cysteine residues included in thiolate clusters and 
various amino acid residues (Tyr, Trp, Met, Lys and Arg 
(Meucci et al., 1998). The thiolate groups of the protein 
contribute physiologically to the redox balance and 
modulate oxidative stress (Hultqvist et al., 1997). In this 
study our results are in agreement (Yilmaz et al., 2003; 
Wrattein et al., 2000; Mallliaraki et al., 2003) with the 
groups mentioned in that the plasma level of 
malondialdehyde (increasing level of MDA) and 
endogenous non-enzymic antioxidants (decreasing level 
of uric acid and increasing level of albumin and total 
bilirubin in dialysis group but not a meaningful increase 
when compared with control groups) of haemodialysis 
patients is significantly different from that of control. But 
our results are not in agreement with the other studies 
(Malliaraki et al., 2003; Gonenc et al., 2002). Different 
explanations for these results could be suggested: 
• 	 Water elimination during dialysis causes increased 
concentration of endogenous antioxidant substances 
(Meucci et al., 1998 ). 
• 	 Elimination of uric acid modifies the equilibrium 
between oxidized and reduced status of endogenous 
and exogenous antioxidants (Canestrari et al., 1995; 
Hultqvist et al., 1997). 
• 	 The elimination of water-soluble metabolic 
antioxidants (uric acid) modifies the equilibrium of 
lipid and water-soluble antioxidants (Barbaste et al., 
2002). 
The observation of meaningful increasing level of 
plasma lipid peroxidation and the significant differenece 
of non-enzyrn1c antioxidants between pre- and 
postdialysis group in the haemodialyzed pateints after the 
process of dialysis, maybe related with the pateint uremia, 
the quality of consumed water in the dialysis procedure, 
dialysis membrane and the loss of these antioxidants 
through membranes and hemoconcenteration of them 
during the dialysis process and the dialysis process self 
(may increase lipid peroxidation during the dialysis 
process). These states of affairs may play an important 
role in progress of cardiovascular abnormality in 
haemodialyzed pateints. Due to this conditions a review 
of haemodialysis membrane, the techniques used in the 
dialysis, the consumption of various oral antioxidant, the 
elimination of active oxygens from the dialysis 
surrounding are among the measures which can prevent 
sudden cardiovascular abnormality in the haemodialysis 
pateints and ultimately these important factors up- grade 
the pateints quality of life and prevent sudden silent 
myocardial infarction. 
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